Integrating novel agents into multiple myeloma treatment – current status in Switzerland and treatment recommendations

Christian Taverna; Mario Bargetzi; Daniel Betticher; Jürg Gmür; Michael Gregor; Dominik Heim; Urs Hess; Nicolas Ketterer; Erika Lerch; Thomas Matthes; Ulrich Mey; Thomas Pabst; Christoph Renner

doi:10.4414/smw.2010.12989

Review article: Biomedical intelligence

Vol. 140 No. 1516 (2010)

Integrating novel agents into multiple myeloma treatment – current status in Switzerland and treatment recommendations

Christian Taverna
Mario Bargetzi
Daniel Betticher
Jürg Gmür
Michael Gregor
Dominik Heim
Urs Hess
Nicolas Ketterer
Erika Lerch
Thomas Matthes
Ulrich Mey
Thomas Pabst
Christoph Renner

Fulltext PDF

DOI: https://doi.org/10.4414/smw.2010.12989
Cite this as:: Swiss Med Wkly. 2010;140:1-21
Published: 24.04.2010

How to Cite

1.

Taverna C, Bargetzi M, Betticher D, Gmür J, Gregor M, Heim D, Hess U, Ketterer N, Lerch E, Matthes T, Mey U, Pabst T, Renner C. Integrating novel agents into multiple myeloma treatment – current status in Switzerland and treatment recommendations. Swiss Med Wkly [Internet]. 2010 Apr. 24 [cited 2024 Nov. 28];140(1516):1-21. Available from: https://smw.ch/index.php/smw/article/view/1111

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Most read articles by the same author(s)

Adalgisa Condoluci, Marie Théaudin, Rahel Schwotzer, Aju P. Pazhenkottil, Paolo Arosio, Manuela Averaimo, Ulrike Bacher, Peter Bode, Andrea Cavalli, Stefan Dirnhofer, Nadia Djerbi, Stephan Dobner, Thomas Fehr, Maura Garofalo, Ariana Gaspert, Sabine Gerull, Raphael Heimgartner, Annemarie Hübers, Hans H. Jung, Chiara Kessler, Raphael Knöpfel, Natallia Laptseva, Giulia Magini, Robert Manka, Luca Mazzucchelli, Martin Meyer, Violeta Mihaylova, Pierre Monney, Alessio Mylonas, René Nkoulou, Thomas Pabst, Otmar Pfister, Axel Rüfer, Adrian Schmidt, Harald Seeger, Simon F. Stämpfli, Guido Stirnimann, Thomas Suter, Giorgio Treglia, Alexandar Tzankov, Friederike Vetter, Markus Zweier, Andreas J. Flammer, Bernhard Gerber, Management of transthyretin amyloidosis , Swiss Medical Weekly: Vol. 151 No. 4142 (2021)
Rahel Schwotzer, Andreas J. Flammer, Sabine Gerull, Thomas Pabst, Paolo Arosio, Manuela Averaimo, Ulrike Bacher, Peter Bode, Andrea Cavalli, Adalgisa Condoluci, Stefan Dirnhofer, Nadia Djerbi, Stephan W. Dobner, Thomas Fehr, Maura Garofalo, Ariana Gaspert, Raphael Heimgartner, Annemarie Hübers, Hans H. Jung, Chiara Kessler, Raphael Knöpfel, Natallia Laptseva, Robert Manka, Luca Mazzucchelli, Martin Meyer, Violeta Mihaylova, Pierre Monney, Alessio Mylonas, René Nkoulou, Aju P. Pazhenkottil, Otmar Pfister, Axel Rüfer, Adrian Schmidt, Harald Seeger, Simon F. Stämpfli, Guido Stirnimann, Thomas Suter, Marie Théaudin, Giorgio Treglia, Alexandar Tzankov, Friederike Vetter, Markus Zweier, Bernhard Gerber, Expert recommendation from the Swiss Amyloidosis Network (SAN) for systemic AL-amyloidosis , Swiss Medical Weekly: Vol. 150 No. 4950 (2020)
Albina Nowak, Anne Angelillo-Scherrer, Daniel Betticher, Michael Dickenmann, Idris Guessous, Pascal Juillerat, Wolfgang Korte, Stefan Neuner-Jehle, Otmar Pfister, Daniel Surbek, Edouard Battegay, Johann Steurer, Swiss Delphi study on iron deficiency , Swiss Medical Weekly: Vol. 149 No. 2728 (2019)
Jakob R. Passweg, Helen Baldomero, Marc Ansari, Gabriela M. Baerlocher, Mario Bargetzi, Yves Chalandon, Michel A. Duchosal, Sabine Gerull, Tayfun Güngör, Jörg P. Halter, Dominik Heim, Urs Hess, Kurt Leibundgut, Stavroula Masouridi-Levrat, Antonia Müller, Gayathri Nair, Thomas Pabst, Christoph Renner, Adrian Schmidt, Georg Stussi, Grazia Nicoloso de Faveri, Urs Schanz, for the Swiss Blood Stem Cell Transplantation Group (SBST), Haematopoietic cell transplantation in Switzerland, changes and results over 20 years: a report from the Swiss Blood Stem Cell Transplantation Working Group for Blood and Marrow Transplantation registry 1997–2016 , Swiss Medical Weekly: Vol. 148 No. 0910 (2018)
Dominik Heim, Helen Baldomero, Michael Medinger, Stavroula Masouridi-Levrat, Urs Schanz, Gayathri Nair, Tayfun Güngör, Jörg Halter, Jakob R. Passweg, Yves Chalandon, Swiss Stem Cell Transplantation Group (SBST), Allogeneic haematopoietic cell transplantation for chronic myeloid leukaemia in Switzerland in the face of rapid development of effective drugs , Swiss Medical Weekly: Vol. 154 No. 5 (2024)
Rüdiger Müller, Christoph Renner, Cem Gabay, Giuseppe Cassata, Andreas Lohri, Paul Hasler, The advent of biosimilars: challenges and risks , Swiss Medical Weekly: Vol. 144 No. 2728 (2014)
Ulrich J. M. Mey, Felicitas Hitz, Andreas Lohri, Stefanie Pederiva, Christian Taverna, Alexander Tzankov, Oliver Meier, Karen Yeow, Christoph Renner, Diagnosis and treatment of diffuse large B-cell lymphoma , Swiss Medical Weekly: Vol. 142 No. 0506 (2012)
Mario Bargetzi, Reto Baumann, Sergio Cogliatti, Pierre-Yves Dietrich, Michel André Duchosal, Jeroen S. Goede, Felicitas Hitz, Carolin Konermann, Andreas Lohri, Ulrich Mey, Urban Novak, Alexandros Papachristofilou, Frank Stenner, Christian Taverna, Thilo Zander, Christoph Renner, Diagnosis and treatment of follicular lymphoma: an update , Swiss Medical Weekly: Vol. 148 No. 2930 (2018)
Jakob Passweg, Helen Baldomero, Mario Bargetzi, Christoph Bucher, Yves Chalandon, Michel A. Duchosal, Alois Gratwohl, Tayfun Güngör, Urs Hess, Kurt Leibundgut, Grazia Nicoloso de Faveri, Hulya Ozsahin, Thomas Pabst, Christoph Renner, Martin Stern, Georg Stussi, Urs Schanz, for the SBST (Swiss Blood Stem Cell Transplantation Group), Haematopoietic stem cell transplantation: activity in Switzerland compared with surrounding European countries , Swiss Medical Weekly: Vol. 143 No. 0708 (2013)
Caroline Arber, Gabriela Baerlocher, Yves Chalandon, Michael Daskalakis, Michel Duchosal, Martin Fehr, Sabine Gerull, Tayfun Güngör, Gayathri Nair, Thomas Pabst, Jakob R. Passweg, Barbara Piccolruaz, Christoph Renner, Axel Ruefer, Dominik Schneidawind, Georg Stüssi, Sacha Zeerleder, Jörg P. Halter, Technical comment on: Trottmann M, et al. Real-world expenditures and survival time after CAR-T treatment for large B-cell lymphoma in Switzerland: a retrospective study using insurance claims data , Swiss Medical Weekly: Vol. 154 No. 10 (2024)

1 2 3 > >>